The hidden burden of measles in Ethiopia: How distance to hospital shapes the disease mortality rate

listen audio

Study Justification:
– The study aimed to estimate the burden of measles in the South West Shoa Zone of the Oromia Region, Ethiopia, and identify inequalities in access to healthcare due to travel distances from the nearest hospital.
– The study aimed to highlight the impact of spatial heterogeneity in healthcare access on the burden of measles disease in low-income settings.
– The study aimed to assess the effectiveness of the public health system in detecting severe measles infections and preventing deaths.
Study Highlights:
– A total of 1819 case patients and 36 deaths were recorded at the hospital during the study period.
– The estimated reproduction number (R0) for measles was 16.5, indicating high transmissibility.
– The cumulative disease incidence was estimated to be 2.34% in the hospital’s catchment area.
– Spatial analysis revealed spatial heterogeneities in the effectiveness of the public health system in detecting severe measles infections and preventing deaths.
– The case fatality rate was found to increase with travel distance from the nearest hospital, ranging from 0.6% to more than 19% at 20 km.
– Hospital treatment was estimated to have prevented 1049 deaths in the area.
Recommendations for Lay Reader:
– Improve access to healthcare in low-income settings to reduce the burden of measles disease.
– Increase vaccination coverage to prevent measles infections and reduce the risk of severe cases and deaths.
– Implement strategies to address spatial heterogeneities in healthcare access and improve detection and prevention of severe measles infections.
Recommendations for Policy Maker:
– Allocate resources to improve healthcare infrastructure, particularly in areas with limited access to hospitals.
– Strengthen vaccination programs to ensure high coverage and reach vulnerable populations.
– Develop targeted interventions to address spatial disparities in healthcare access and improve disease detection and prevention.
– Support research and surveillance efforts to monitor measles disease burden and evaluate the effectiveness of interventions.
Key Role Players:
– Ministry of Health: Responsible for overall coordination and implementation of healthcare interventions.
– Local government authorities: Responsible for allocating resources and implementing healthcare programs at the regional and district levels.
– Healthcare providers: Responsible for delivering healthcare services, including vaccination and treatment for measles.
– Community leaders and organizations: Involved in raising awareness, promoting vaccination, and advocating for improved healthcare access.
Cost Items for Planning Recommendations:
– Healthcare infrastructure development: Construction and renovation of hospitals, clinics, and health posts.
– Vaccine procurement and distribution: Cost of purchasing measles vaccines and distributing them to healthcare facilities.
– Training and capacity building: Cost of training healthcare workers on vaccination, disease detection, and treatment.
– Outreach and awareness campaigns: Cost of organizing community outreach programs, health education sessions, and awareness campaigns.
– Research and surveillance: Cost of conducting studies, collecting data, and monitoring disease burden and intervention effectiveness.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong because it presents findings from a study conducted in a specific region in Ethiopia, provides detailed methodology, and includes specific results and conclusions. However, to improve the evidence, the abstract could include information on the sample size, data collection methods, and statistical analysis used in the study.

Background: A sequence of annual measles epidemics has been observed from January 2013 to April 2017 in the South West Shoa Zone of the Oromia Region, Ethiopia. We aimed at estimating the burden of disease in the affected area, taking into account inequalities in access to health care due to travel distances from the nearest hospital. Methods: We developed a dynamic transmission model calibrated on the time series of hospitalized measles cases. The model provided estimates of disease transmissibility and incidence at a population level. Model estimates were combined with a spatial analysis to quantify the hidden burden of disease and to identify spatial heterogeneities characterizing the effectiveness of the public health system in detecting severe measles infections and preventing deaths. Results: A total of 1819 case patients and 36 deaths were recorded at the hospital. The mean age was 6.0 years (range, 0-65). The estimated reproduction number was 16.5 (95% credible interval (CI) 14.5-18.3) with a cumulative disease incidence of 2.34% (95% CI 2.06-2.66). Three thousand eight hundred twenty-one (95% CI 1969-5671) severe cases, including 2337 (95% CI 716-4009) measles-related deaths, were estimated in the Woliso hospital’s catchment area (521,771 inhabitants). The case fatality rate was found to remarkably increase with travel distance from the nearest hospital: ranging from 0.6% to more than 19% at 20 km. Accordingly, hospital treatment prevented 1049 (95% CI 757-1342) deaths in the area. Conclusions: Spatial heterogeneity in the access to health care can dramatically affect the burden of measles disease in low-income settings. In sub-Saharan Africa, passive surveillance based on hospital admitted cases might miss up to 60% of severe cases and 98% of related deaths.

This study was conducted in the South West Shoa Zone of the Oromia Region in Ethiopia (Fig. 1a), with an estimated population of 1,341,702 inhabitants in 2014, of whom 50.3% were men and 49.7% were women. The main hospital is located in Woliso town, 114 km southwest of the capital Addis Ababa, representing the nearest hospital for 521,771 individuals living within an area of 30 km radius from Woliso town (53,065 inhabitants). The hospital has 200 beds with an annual average bed-occupation rate of 84%; single-patient air-borne infection isolation rooms are not available in the hospital. Epidemiological evidences: a Study area and spatial distribution of woredas. b Age distribution of measles patients hospitalized at the Woliso hospital between January 2013 and April 2017. The inset shows the estimated measles seroprevalence by age, as obtained on the basis of model estimates. c Time series of case patients recorded during the study period, overall, and in most affected woredas. The inset shows the cross correlation in the timing of epidemics in Woliso and most rural areas. d Cumulative incidence of hospitalizations per 10,000 individuals (h) by woreda/kebele and distance from Woliso hospital (d). The solid line represents estimates obtained by the negative binomial regression model; the shaded area represents 95% CI Data on age, sex, residence at woreda (i.e., district) and kebele (i.e., neighborhood) level, date of hospital admission, and death/discharge of measles case patients from 2013 to 2017 were obtained from the registers of Woliso hospital. Incidence of hospitalizations by woreda and kebele were calculated by assuming population projections for the 2014, based on the 2007 census conducted by the Central Statistical Agency of Ethiopia (Table 1) [15]. Travel distances to the Woliso hospital for different kebeles and woredas were obtained from administrative hospital records on distances of all health posts and largest villages distributed in the main hospital’s catchment area (see Table 1). The case fatality rate (CFR) for hospital admitted cases was calculated as the percentage of fatal cases among measles patients recorded. Routine vaccination coverage for this area was derived from administrative records: on average, 88% of children are routinely vaccinated against measles at 9 months of age. Two immunization campaigns were conducted in the area from May 29 to June 5, 2013, and from March 13 to March 20, 2017, targeting children 9–59 months of age [16]; the achieved vaccination coverage is unknown. In 2016, the vaccination status of case patients was assessed for 295 children in the age group 9 months to 5 years. Measles cases patients. Epidemiological characteristics of measles cases admitted to Woliso hospital (South West Shewa Zone, Oromia Region, Ethiopia) from January 1, 2013, to April 9, 2017 Patients’ records related to different illness conditions recorded at the Woliso hospital between 2014 and 2016 were considered to estimate hospitalization incidence over time and to assess differences in the access to health care and related outcomes with respect to travel distances from the hospital. Collected data consisted of routine health data and medical records, were encrypted and anonymous, and did not contain any information that might be used to identify individual patients; therefore, the study did not require informed consent. Synchrony in the timing of epidemics across different woredas was assessed by calculating the cross-correlation of time series at different time lags. The aim of this analysis is twofold: (i) to evaluate whether the observed seasonal pattern is an artifact of averaging asynchronous local epidemics and (ii) to support the hypothesis that observed measles cases were the result of a unique synchronous epidemic with similar epidemiological characteristics across different woredas. The baseline analysis combines results of a dynamic transmission model, calibrated on the time series of hospitalized measles cases occurring between 2013 and 2017, with a spatial regression analysis, providing estimates of the measles hospitalization rate at different distances from the Woliso hospital. We restricted the analysis to measles cases from Woliso, Wonchi, Ameya, and Goro woredas, which represent the main hospital catchment area, consisting of 521,771 inhabitants and accounting for 83.1% of recorded case patients. Under the assumption of homogeneous mixing transmission, the baseline model provided estimates of the basic reproductive number (R0), the age-specific immunity profile, and the average measles incidence in the considered area. The estimated total number of infection cases in the population was disaggregated into smaller spatial units (woredas and kebeles), by assuming the same incidence rate across all spatial units and proportionally to the population size of each spatial unit. A regression model was applied to counts of observed hospitalized cases in each spatial unit to estimate the corresponding hospitalization rate; distance from the hospital was used as the independent variable and the estimated total number of cases in each spatial unit as offset. Obtained results were used to quantify the hidden burden of measles disease. In the rest of this section, we detail the dynamic transmission model, the performed spatial analysis, how we calculated the hidden burden of disease, and the performed sensitivity analyses. Measles transmission dynamics between 2013 and 2017 is simulated through a deterministic, non-stationary, age-structured transmission model. In the model, the population is stratified in 86 1-year age classes, according to available data on the age distribution of the Ethiopian population in 2013 [17]. The crude birth rate of the population is 0.0325 years−1; individuals die according to age-specific mortality rates as reported between 2013 and 2015 and reflecting a crude mortality rate of 0.0083 days−1 [17]. The population of any age a is divided into five epidemiological classes: individuals protected by maternal antibodies (Ma), susceptible individuals (Sa), exposed individuals (Ea), infectious individuals (Ia), and individuals who acquired immunity against measles through either vaccination or natural infection (Ra). We assume that newborn individuals are protected against measles infection for 6 months on average by the passive transfer of maternal immunity [1], after which they become susceptible to the infection. Susceptible individuals can acquire infection after contact with an infectious individual under the assumption of homogeneous mixing and become exposed without symptoms; at the end of the latent period, lasting 7.5 days on average, infectious individuals can transmit the infection for 6.5 days on average; the resulting generation time is 14 days [18]. After recovery, individuals are assumed to gain lifelong immunity. Newly infected individuals are hospitalized with a certain, age-independent, probability ph, representing the average hospitalization rate in the main hospital catchment area. Seasonal variations in the transmission rate are considered: during school holidays, overlapping with the rainy season [14], the transmission rate is decreased by a factor r. Routine vaccination of children is simulated at 9 months of age [3] with homogenous coverage across woredas at 88%. The latter estimate was obtained by administrative records on infant immunization occurring between 2013 and 2016 in the main hospital catchment area. Vaccine efficacy at the first dose of routine administration is assumed at 85% [19]. The follow-up campaigns conducted in 2013 (from May 29 to June 5) and in 2017 (from March 13 to March 20), targeting children 9–59 months of age [16], are also considered. The coverage of the 2013 supplementary immunization activities (SIAs), cS, was estimated among free model parameters. Vaccine efficacy during SIAs is assumed to be 95% [19]. Epidemiological transitions are described by the following system of ordinary differential equations: where t represents time and a the individuals’ chronological age; b(t) and d(t,a) are the crude birth and the age-specific mortality rates at time t; 1/μ is the average duration of protection provided by maternal antibodies; 1/ ω and 1/γ are the average duration of the latent and the infectivity periods; cR(t, a) and cS(t, a) are the coverage associated with the first-dose routine vaccination and SIAs for individuals of age a, at time t; εR and εS represent the vaccine efficacy associated with routine vaccination of infants and SIAs. Specifically, cS denotes the vaccinated fraction of individuals who were not yet immunized by natural infection or routine programs. N(t) and H(t) represent the total population of the hospital main catchment area and the cumulative number of hospitalized measles cases at time t; ph is the fraction of measles infections that are hospitalized, and β(t) is the measles transmission rate defined as follows: At the end of the year, the chronological age of individuals is incremented by 1. The number of hospitalized measles cases in a time interval [t1,t2] is computed as H(t2) − H(t1). Model estimates were obtained by simulating measles transmission between January 1, 2013, and March 20, 2017. Simulations are initialized on January 1, 2013. As the result of past natural infection and immunization campaigns, only a fraction s0 of the population is assumed to be susceptible to the infection. The age distribution of susceptibles at the beginning of 2013 was assumed to mirror the age distribution of hospitalized cases between January 2013 and March 2017. Specifically, the initial fraction of susceptible and immune individuals in each age group are Sa(0) = Nas0Za/∑a=085Za and Ra(0) = Na − Sa(0), respectively, where Na is the number of individuals of age a at the beginning of 2013 in Woliso, Ameya, Goro, and Wonchi [17] and Za is the observed total number of hospitalized measles cases of age a. Free model parameters (s0, β, rβ, ph, cS) were calibrated using a Markov Chain Monte Carlo (MCMC) approach based on the negative binomial likelihood of observing the weekly number of hospitalized case patients reported between January 1, 2013, and the beginning of the 2017 SIA. The scale parameter defining the negative binomial distribution was jointly estimated with other free parameters within the MCMC procedure. Details are provided in the Additional file 1. The fundamental quantity regulating disease dynamics is the basic reproduction number (defined as R0 = 〈β〉/γ, where 〈β〉 is the average of β(t) over the year), which represents the average number of secondary infections in a fully susceptible population generated by a typical index case during the entire period of infectiousness. The larger the R0, the higher the disease transmissibility. If R0 > 1, the infection will be able to spread in a population. Otherwise, the infection will die out. For endemic diseases like measles, R0 provides insights into the proportion p of population to be successfully vaccinated to achieve disease elimination; the equation p = 1–1/R0 is widely accepted (e.g., [5, 18, 20]). For instance, if R0 = 10, at least 90% of children have to be routinely immunized to eliminate the disease. A negative binomial regression was used to study the relationship between incidence of hospitalization by kebeles/woredas and distance from Woliso hospital. Specifically, the observed number of hospitalized cases from each spatial unit is the response variable, the distance from the hospital is the independent variable, and the estimated total number of measles cases in each spatial unit (as estimated by the transmission model) is used as the offset. Detailed origin of patients at the kebele level was used to better identify the travel distances for patients living within the Woliso woreda, where the hospital is located (Table 1). In the negative binomial regression, we assume that counts of hospitalized cases hi (the response variable) associated with a given location i are distributed as a negative binomial of mean μi determined by the number of infection in the location ci (the offset) and the distance of location from the hospital di (the regressor) as follows: where b1, b2 are unknown parameters that are estimated from the observed hospitalized cases hi. In order to take into account the uncertainty on incidence estimates obtained with the dynamic model, 10,000 draws from the posterior distribution of incidence estimates associated with 10,000 samples of the posterior distribution of free model parameters were considered to generate a distribution of regression model fits. Obtained results therefore account for the combined uncertainty due to the regression model and the dynamic transmission model. We investigate the spatial variation in the incidence of hospitalized patients in the population as a consequence of different illness conditions. The aim is to characterize the relationship between hospitalization and distance from the hospital. The relative risk of being hospitalized at different distances from the hospital was computed by considering the incidence of hospitalization in each kebele/woreda divided by the incidence of hospitalized cases from Woliso town. The relative risk was fitted by an exponential function using distance as the independent variable (i.e., by fitting a linear model to the logarithm of the relative risk without intercept). Finally, a proportional test was used to assess possible statistical differences in the case fatality rate at hospital between cases coming from different sites. Persons living in Woliso town do not have distance barriers to access to the Woliso hospital. The probability of severe disease after measles infection was therefore computed as the fraction of measles patients from Woliso town that have been hospitalized for two nights or more among all measles infections estimated by the transmission model for this spatial unit. For severe cases, we indicate here those cases that from a clinical point of view are physiologically unstable and require supportive care (fluid resuscitation, oxygen, etc.) that can be provided only inside a well-resourced hospital. The resulting probability of developing severe measles illness ps was used in combination with the estimated number of measles infections at different kebeles and woredas ci to estimate the potential number of severe cases occurring at different distances from the hospital as psci. For each considered spatial unit i, missed severe cases were computed as the difference between the estimated number of severe cases and the number of patients recorded at the hospital, namely mis=psci−hi. Missed severe cases were considered untreated and counted as additional deaths. The overall number of deaths caused by measles was estimated as the sum of missed deaths and measles deaths observed among hospital admitted patients. Averted deaths due to hospital treatment were estimated by considering all severe cases psci as counterfactual deaths that would have occurred in the absence of adequate treatment. A variety of sensitivity analyses were conducted to evaluate to what extent some crucial assumptions made in the above described analysis may affect the obtained results. We evaluated whether the assumption of decreased transmissibility during school holidays (or rainy season) is necessary to explain the observed pattern, by fitting a model with constant transmission rate against the time series of measles hospitalized cases. Since the fraction of immunized individuals during the SIA in 2013 is unknown, we also considered two alternative models with cS = 0 (SIA not conducted in 2013 in the considered area) and cS = 0.92 (the highest coverage reported for past campaigns, namely 92% [3]). We explored whether the assumption of homogeneous mixing, consisting in applying the same transmission rate to all age groups, can affect the model ability in reproducing the observed epidemiological patterns. To do this, we fitted the time series of cases with a transmission model encoding age-specific contacts as recently estimated for Ethiopia by Prem et al. [21]. In this case, increased mixing in schools corresponds to higher transmission rate among school-age children. Models’ performances were assessed through the Deviance Information Criterion (DIC). A sensitivity analysis was also conducted by fitting a transmission model to the time series of measles cases observed in Woliso, Wonchi, Ameya, and Goro separately. Specifically, a single epidemic was simulated in the four woredas simultaneously, by assuming the same initial conditions and by assuming that populations from different locations mix homogeneously. All epidemiological parameters were assumed to be equal across different woredas, but a different hospitalization rate was considered for each woreda. An additional sensitivity analysis was performed to test whether estimates on the spatial variation of the hospitalization rates change when patients recorded from all woredas of the South West Shoa Zone are considered or when patients’ sex is considered. Finally, estimates on the overall number of measles deaths and on the overall case fatality rate were estimated by relaxing the assumption that all missed/untreated severe measles cases die. Details are provided in Additional file 1.

Based on the information provided, here are some potential innovations that could improve access to maternal health:

1. Telemedicine: Implementing telemedicine services can help overcome the challenge of distance by allowing pregnant women to consult with healthcare professionals remotely. This can provide access to prenatal care, advice, and support, reducing the need for travel to healthcare facilities.

2. Mobile clinics: Setting up mobile clinics that travel to remote areas can bring essential maternal healthcare services closer to communities. These clinics can provide prenatal check-ups, vaccinations, and education on maternal health.

3. Community health workers: Training and deploying community health workers can improve access to maternal health services. These workers can provide basic prenatal care, education, and referrals to healthcare facilities when necessary.

4. Emergency transportation services: Establishing emergency transportation services, such as ambulances or motorcycle taxis, can ensure that pregnant women have timely access to healthcare facilities in case of complications during pregnancy or childbirth.

5. Health information systems: Implementing digital health information systems can improve coordination and communication between healthcare facilities, enabling better tracking of pregnant women and ensuring continuity of care. This can help identify high-risk pregnancies and ensure appropriate interventions are provided.

6. Maternal waiting homes: Building maternal waiting homes near healthcare facilities can provide a safe and comfortable place for pregnant women to stay as they approach their due dates. This can reduce the need for long-distance travel and ensure timely access to healthcare during labor and delivery.

7. Mobile apps and SMS reminders: Developing mobile applications or using SMS reminders can help pregnant women receive timely information about prenatal care, vaccination schedules, and upcoming appointments. This can improve adherence to recommended care and help women stay informed about their health.

8. Training and capacity building: Investing in training and capacity building for healthcare professionals in remote areas can improve the quality of maternal healthcare services. This can include training on emergency obstetric care, neonatal resuscitation, and other essential skills.

9. Public-private partnerships: Collaborating with private sector organizations can help leverage resources and expertise to improve access to maternal health services. This can involve partnerships with telecommunications companies for telemedicine services or with transportation providers for emergency transportation.

10. Policy and advocacy: Advocating for policies that prioritize maternal health and address barriers to access can create an enabling environment for innovation and improvement. This can include policies that support the deployment of community health workers, the integration of digital health solutions, and the provision of emergency transportation services.

It is important to note that the specific context and needs of the South West Shoa Zone in Ethiopia should be taken into consideration when implementing these innovations. Local stakeholders, including healthcare providers, policymakers, and community members, should be involved in the design and implementation process to ensure the innovations are tailored to the local context and effectively address the barriers to maternal health access.
AI Innovations Description
Based on the information provided, the study highlights the importance of addressing spatial heterogeneity in access to healthcare in order to improve maternal health outcomes. Here are some recommendations that can be used to develop innovations to improve access to maternal health:

1. Mobile Health Clinics: Implementing mobile health clinics that can travel to remote areas, bringing essential maternal health services closer to communities. These clinics can provide prenatal care, vaccinations, and emergency obstetric care.

2. Telemedicine: Utilizing telemedicine technology to connect healthcare providers with pregnant women in remote areas. This allows for remote consultations, monitoring of maternal health, and timely access to medical advice.

3. Community Health Workers: Training and deploying community health workers who can provide basic maternal health services, education, and support in remote areas. These workers can also serve as a bridge between the community and healthcare facilities.

4. Transportation Solutions: Improving transportation infrastructure and services to ensure that pregnant women can easily access healthcare facilities. This may include providing transportation vouchers, establishing ambulance services, or improving road networks.

5. Health Education and Awareness: Conducting health education campaigns to raise awareness about the importance of maternal health and the available services. This can help overcome cultural barriers and encourage women to seek timely care.

6. Strengthening Healthcare Facilities: Investing in the improvement and expansion of healthcare facilities in underserved areas. This includes ensuring the availability of skilled healthcare providers, essential medical equipment, and necessary medications.

7. Public-Private Partnerships: Collaborating with private sector organizations to leverage their resources and expertise in improving access to maternal health services. This can include partnerships with private hospitals, pharmaceutical companies, and technology companies.

It is important to tailor these recommendations to the specific context and needs of the South West Shoa Zone in Ethiopia. Additionally, ongoing monitoring and evaluation should be conducted to assess the effectiveness of these innovations in improving access to maternal health and reducing maternal mortality rates.
AI Innovations Methodology
Based on the information provided, here are some potential recommendations to improve access to maternal health:

1. Improve transportation infrastructure: Enhancing road networks and transportation systems can reduce travel distances and improve access to maternal health facilities. This can include building new roads, improving existing ones, and providing reliable public transportation options.

2. Establish mobile health clinics: Mobile health clinics can bring essential maternal health services to remote and underserved areas. These clinics can provide prenatal care, vaccinations, and emergency obstetric care, among other services.

3. Strengthen community health worker programs: Training and deploying community health workers can help bridge the gap between communities and formal healthcare facilities. These workers can provide education, counseling, and basic healthcare services to pregnant women and new mothers in their own communities.

4. Implement telemedicine solutions: Telemedicine can enable remote consultations and monitoring of pregnant women, reducing the need for travel to healthcare facilities. This can be particularly beneficial for women in remote areas who have limited access to healthcare services.

5. Increase awareness and education: Promoting maternal health awareness and education can empower women to seek timely and appropriate care. This can be done through community outreach programs, health campaigns, and the use of local media channels.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define indicators: Identify key indicators that reflect access to maternal health, such as the number of pregnant women receiving prenatal care, the number of deliveries attended by skilled birth attendants, and the distance traveled to reach healthcare facilities.

2. Collect baseline data: Gather data on the current status of these indicators in the target area. This can be done through surveys, interviews, and analysis of existing health records.

3. Develop a simulation model: Create a simulation model that incorporates the recommended innovations and their potential impact on the identified indicators. This model should consider factors such as population distribution, transportation networks, and healthcare facility capacity.

4. Input data and run simulations: Input the baseline data into the simulation model and run multiple simulations to assess the potential impact of the recommended innovations. Vary the parameters and assumptions to capture different scenarios and uncertainties.

5. Analyze results: Analyze the simulation results to determine the potential improvements in access to maternal health. Evaluate the changes in the identified indicators and assess the effectiveness of each recommendation.

6. Refine and validate the model: Refine the simulation model based on feedback and validation from relevant stakeholders, such as healthcare providers, policymakers, and community members. Incorporate additional data and insights to improve the accuracy and reliability of the model.

7. Communicate findings and make recommendations: Present the simulation findings to stakeholders and decision-makers, highlighting the potential benefits of the recommended innovations. Use the results to inform policy and planning decisions aimed at improving access to maternal health.

By following this methodology, stakeholders can gain insights into the potential impact of different innovations and make informed decisions to improve access to maternal health in the target area.

Partagez ceci :
Facebook
Twitter
LinkedIn
WhatsApp
Email